|
MRPL53 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.554350E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.525630E-01 |
| Normal-vs-Stage2 |
9.122800E-01 |
| Normal-vs-Stage3 |
5.475700E-02 |
| Normal-vs-Stage4 |
6.570100E-02 |
| Stage1-vs-Stage2 |
2.079400E-01 |
| Stage1-vs-Stage3 |
3.626200E-01 |
| Stage1-vs-Stage4 |
4.408000E-01 |
| Stage2-vs-Stage3 |
1.164830E-01 |
| Stage2-vs-Stage4 |
1.269980E-01 |
| Stage3-vs-Stage4 |
9.365000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.067000E-01 |
| Normal-vs-AfricanAmerican |
4.366100E-02 |
| Normal-vs-Asian |
1.457740E-03 |
| Caucasian-vs-AfricanAmerican |
1.389170E-01 |
| Caucasian-vs-Asian |
6.644400E-03 |
| AfricanAmerican-vs-Asian |
6.526800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.830200E-01 |
| Normal-vs-Female |
8.472000E-02 |
| Male-vs-Female |
5.928400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.355200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.055210E-01 |
| Normal-vs-Age(61-80Yrs) |
3.339400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.763400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.616200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.250000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.893600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.257600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.963200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.370400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.341200E-01 |
| Classical-VS-Follicular |
2.3152999999998E-05 |
| Classical-VS-Other |
4.329400E-01 |
| Classical-VS-Normal |
9.717600E-03 |
| Tall-VS-Follicular |
7.72770000000422E-05 |
| Tall-VS-Other |
1.591750E-01 |
| Tall-VS-Normal |
4.037500E-03 |
| Follicular-VS-Other |
4.567000E-01 |
| Follicular-VS-Normal |
2.045400E-01 |
| Other-VS-Normal |
7.729600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.562800E-01 |
| Normal-vs-N1 |
1.584570E-01 |
| N0-vs-N1 |
1.965580E-01 |
|
|
